The case for endoscopic treatment of non-dysplastic and low-grade dysplastic barrett's esophagus

Digestive Diseases and Sciences

Volumn 55, Issue 7, 2010, Pages 1918-1931

  Fleischer, David E ^a   Odze, Robert ^b   Overholt, Bergein F ^c   Carroll, John ^d   Chang, Kenneth J ^e   Das, Ananya ^a   Goldblum, John ^f   Miller, Daniel ^g   Lightdale, Charles J ^h   Peters, Jeffrey ⁱ   Rothstein, Richard ^j   Sharma, Virender K ^k   Smith, Daniel ^l   Velanovich, Victor ^m   Wolfsen, Herbert ^l   Triadafilopoulos, George ⁿ  

^a MAYO CLINIC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Gastrointestinal Associates   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h New York Presbyterian Hospital Columbia University Medical Center   (United States)

ⁱ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^j DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^k Az Center for Digestive Health   (United States)

^l MAYO CLINIC   (United States)

^m HENRY FORD HOSPITAL   (United States)

ⁿ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adenocarcinoma; Barrett's esophagus; Esophageal cancer; Intestinal metaplasia; Low grade dysplasia; Radiofrequency ablation

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER RISK; COST EFFECTIVENESS ANALYSIS; DYSPLASIA; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SQUAMOUS EPITHELIUM; STOMACH FUNDOPLICATION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY, NEEDLE; CATHETER ABLATION; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PRECANCEROUS CONDITIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 77954426861     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1218-1     Document Type: Article

References (106)

1. P Sharma 2009 Clinical practice. Barrett's esophagus N Engl J Med 361 2548 2556 20032324
2. RC Haggitt 1994 Barrett's esophagus: pathogenesis, dysplasia, and adenocarcinoma Hum Pathol 25 982 993 7927321
3. RC Fitzgerald R Lascar G Triadafilopoulos 2001 Barrett's esophagus, dysplasia and pharmacologic acid suppression Aliment Pharmacol Ther 15 269 276 11207503
4. RD Odze 2008 Update on the diagnosis and treatment of Barrett's esophagus and related neoplastic precursor lesions Arch Pathol Lab Med 132 1577 1585 18834215
5. RH Riddell RD Odze 2009 Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead? Am J Gastroenterol 104 2588 2594 19623166
6. J Ronkainen P Aro T Storskrubb, et al. 2005 Prevalence of Barrett's esophagus in the general population: an endoscopic study Gastroenterology 129 1825 1831 16344051
7. RE Sampliner 2005 A population prevalence of Barrett's esophagus-finally Gastroenterology 129 2101 2113 16344076
8. AJ Cameron CT Lomboy 1992 Barrett's esophagus: age, prevalence and extent of columnar epithelium Gastroenterology 103 1241 1245 1397881
9. LB Gerson K Shetler G Triadafilopoulos 2002 Prevalence of Barrett's esophagus in asymptomatic individuals Gastroenterology 123 636 639
10. EM van Soest JP Dieleman PD Siersema, et al. 2005 Increasing incidence of Barrett's esophagus in the general population Gut 54 1062 1066 15857935
11. Horner MJ, et al. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009.
12. S Wani SR Puli NJ Shaheen, et al. 2009 Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review Am J Gastroenterol 104 502 513 19174812
13. KK Wang RE Sampliner 2008 Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 788 797 18341497
14. GS Cooper TD Kou A Chak 2009 Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends Am J Gastroenterol 104 1356 1362 19491849
15. DA Corley TR Levin LA Habel NS Weiss PA Buffler 2002 Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 633 640 11874995
16. BF Overholt CJ Lightdale KK Wang, et al. 2005 Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial Gastrointest Endosc 62 488 498 16185958
17. NJ Shaheen P Sharma BF Overholt, et al. 2009 Radiofrequency ablation in Barrett's esophagus with dysplasia N Engl J Med 360 2277 2288 19474425
18. E Achkar W Carey 1988 The cost of surveillance for adenocarcinoma complicating Barrett's esophagus Am J Gastroenterol 83 291 294 3125739
19. D Provenzale C Schmitt JB Wong 1999 Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk Am J Gastroenterol 94 2043 2053 10445526
20. JM Inadomi R Sampliner J Lagergren D Lieberman AM Fendrick N Vakil 2003 Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis Ann Intern Med 138 3 176 186 12558356
21. JM Inadomi 2009 Surveillance in Barrett's esophagus: a failed premise Keio J Med 58 1 12 18 19398879
22. P Sharma GW Falk AP Weston, et al. 2006 Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus Clin Gastroenterol Hepatol 4 566 572 16630761
23. SD Crockett QK Lippmann ES Dellon NJ Shaheen 2009 Health-related quality of life in patients with Barrett's esophagus: a systematic review Clin Gastroenterol Hepatol 7 6 613 623 19281858
24. K Hormi-Carver R Souza 2009 Molecular markers and genetics in cancer development Surg Oncol Clin N Am 18 3 453 467 19500736
25. LB Koppert B Wijnhoven H Van Dekken, et al. 2005 The molecular biology of esophageal adenocarcinoma J Surg Oncol 92 169 190 16299787
26. LA Lai TG Paulson X Li, et al. 2007 Increasing genomic instability during premalignant neoplastic progression revealed through high-resolution array-CGH Gene Chromosomes Cancer 46 6 532 542
27. X Li PC Galipeau CA Sanchez, et al. 2008 Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression Cancer Prev Res 1 6 413 423
28. DJ Wong TG Paulson LJ Prevo, et al. 2001 p16 INK4a lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium Cancer Res 61 8284 8289 11719461
29. J Gulizia H Wang D Antonioli, et al. 1999 Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short segment Barrett's esophagus) Human Pathol 30 4 412 419
30. MR Gray PA Hall J Nash, et al. 1992 Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immuno-localization Gastroenterology 103 6 1769 1776 1360434
31. CC Maley PC Galipeau X Li, et al. 2004 The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma Cancer Res 64 7629 7633 15492292
32. BT Cooper W Chapman CS Neumann, et al. 2006 Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence Aliment Pharmacol Ther 23 6 727 733 16556174
33. PA Gatenby JR Ramus CP Caygill, et al. 2007 Does the length of the columnar-lined esophagus change with time? Dis Esophagus 20 6 497 503 17958725
34. JJ Herbst MM Berenson DW McCloskey, et al. 1978 Cell proliferation in esophageal columnar epithelium (Barrett's esophagus) Gastroenterology 75 4 683 687 710836
35. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 57 70 10647931
36. PC Galipeau LJ Prevo CA Sanchez, et al. 1999 Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue J Natl Cancer Inst 91 2087 2095 10601379
37. PL Blount PC Galipeau CA Sanchez, et al. 1994 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy Cancer Res 54 2292 2295 8162566
38. K Bani-Hani IG Martin LJ Hardie, et al. 2000 Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma J Natl Cancer Inst 92 1316 1321 10944553
39. CA Eads RV Lord SK Kurumboor, et al. 2000 Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma Cancer Res 60 5021 5026 11016622
40. K Kawakami J Brabender RV Lord, et al. 2000 Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma J Natl Cancer Inst 92 1805 1811 11078757
41. CP Morales EL Lee JW Shay 1998 In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma Cancer 83 652 659 9708927
42. VN Shirvani R Ouatu-Lascar BS Kaur MB Omary G Triadafilopoulos 2000 Cyclooxygenase-2 expression in Barrett's esophagus and esophageal adenocarcinoma: ex-vivo induction by bile salts and acid exposure Gastroenterology 118 487 496 10702199
43. RC Fitzgerald MB Omary G Triadafilopoulos 1996 Dynamic effects of acid on Barrett's esophagus: an ex vivo proliferation and differentiation model J Clin Invest 98 2120 2128 8903332
44. BS Kaur R Ouatu-Lascar RC Fitzgerald MB Omary G Triadafilopoulos 2000 Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion Am J Physiol (Gastrointest Liver Physiol) 278 G1000 G1009
45. P Jiménez E Piazuelo C Cebrian J Ortego, et al. 2010 Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma Aliment Pharmacol Ther 31 3 440 451 19843025
46. G Triadafilopoulos B Kaur S Sood B Traxler D Levine A Weston 2006 Effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's esophagus Aliment Pharmacol Ther 23 997 1005 16573802
47. D Shimizu D Vallböhmer H Kuramochi, et al. 2006 Increasing cyclooxygenase-2 (cox-2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl-2 Int J Cancer 119 4 765 770 16550596
48. PS Rabinovitch G Longton PL Blount, et al. 2001 Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables Am J Gastroenterol 96 3071 3083 11721752
49. W Liu H Hahn RD Odze, et al. 2009 Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell containing epithelium Am J Gastorenterol 81 241 247
50. C Yu X Zhang Q Huang, et al. 2007 High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus Lab Invest 87 466 472 17310216
51. X Zhang Q Huang RK Goyal, et al. 2008 DNA ploidy abnormalities in basal and superficial regions of the crypts in Barrett's esophagus and associated neoplastic lesions Am J Surg Pathol 32 1327 1335 18670357
52. P Chaves M Crespo C Ribeiro, et al. 2007 Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved Mod Pathol 20 788 796 17529926
53. Y Hao G Triadafilopoulos P Sahbaie HS Young MB Omary AW Lowe 2006 Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma Gastroenterology 131 3 925 933 16952561
54. PC Galipeau DS Cowan CA Sanchez, et al. 1996 17p (p53) allelic losses, 4 N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus Proc Natl Acad Sci USA 93 7081 7084 8692948
55. PC Galipeau X Li PL Blount, et al. 2007 NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma PLoS Med 4 342 354
56. JS Wang M Guo EA Montgomery, et al. 2009 DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus Am J Gastroenterol 104 2153 2160 19584833
57. VJ Wongsurawat JC Finley PC Galipeau, et al. 2006 Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation Cancer Epidemiol Biomark Prev 15 3 509 516
58. M Kerkhof EW Steyerberg JG Kusters, et al. 2008 Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett's esophagus Cancer Biomark 4 1 10 18334729
59. RD Odze 2006 Diagnosis and grading of dysplasia in Barrett's oesophagus J Clin Pathol 59 1029 1038 17021130
60. E Montgomery MP Bronner JR Goldblum, et al. 2001 Reproducibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation Hum Pathol 32 368 378 11331953
61. BJ Reid RC Haggitt EC Rubin, et al. 1988 Observer variation in the diagnosis of dysplasia in Barrett's esophagus Human Pathol 19 166 178
62. M Alikhan D Rex A Khan, et al. 1999 Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice Gastrointest Endosc 50 1 23 26 10385717 (Pubitemid 29323284)
63. R Rucker-Schmidt CA Sanchez PL Blount, et al. 2009 Non-adenomatous dysplasia in Barrett's esophagus; a clinical, pathologic and DNA content flow cytometric study Am J Surg Pathol 33 6 886 893 19194279
64. L Lomo PL Blount CA Sanchez, et al. 2006 Crypt dysplasia with surface maturation: a clinical, pathologic and molecular study of a Barrett's esophagus cohort Am J Surg Pathol 30 4 423 435 16625087
65. PA Gatenby JR Ramus CP Caygill, et al. 2008 Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus Scand J Gastroenterol 43 524 530 18415743
66. R Harrison I Perry W Haddadin, et al. 2007 Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies Am J Gastroenterol 102 1154 1161 17433019
67. RD Odze GY Lauwers 2008 Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy Endoscopy 40 1008 1015 19065484
68. MM Berenson TD Johnson NR Markowitz, et al. 1993 Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium Gastroenterology 104 1686 1691 8500727
69. SD Finkelstein WD Lyday 2008 The molecular pathology of radiofrequency mucosa ablation of Barrett's esophagus Gastroenterology 134 A437
70. T Paulson LJ Xu CA Sanchez, et al. 2006 Neosquamous epithelium does not typically arise from Barrett's epithelium Clin Cancer Res 12 1701 1706 16551852
71. RE Pouw JJ Gondrie AM Rygiel, et al. 2009 Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia Am J Gastroenterol 104 6 1366 1373 19491850
72. JL Hornick PL Blount CA Sanchez, et al. 2005 Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus Am J Surg Pathol 29 372 380 15725807
73. JL Hornick M Mino-Kenudson GY Lauwers, et al. 2007 Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities Am J Gastroenterol 103 1 38 47 18076737
74. JA Abrams RC Kapel GM Lindberg, et al. 2009 Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States Clin Gastroenterol Hepatol 7 736 742 19268726
75. R Kariv TP Plesec JR Goldblum, et al. 2009 The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol Clin Gastroenterol Hepatol 6 653 658
76. NJ Shaheen MA Crosby EM Bozymski, et al. 2000 Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119 333 338 10930368
77. J Labenz M Nocon T Lind, et al. 2006 Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease Am J Gastroenterol 101 11 2457 2462 17029609
78. M Skacel RE Petras TL Gramlich, et al. 2000 The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression Am J Gastroenterol 95 3383 3387 11151865
79. P Gatenby J Ramus C Caygill, et al. 2009 Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history Histopathology 54 7 814 819 19635100
80. CH Lim D Treanor MF Dixon AT Axon 2007 Low-grade dysplasia in Barrett's esophagus has a high risk of progression Endoscopy 39 7 581 587 17611911
81. M Vieth 2007 Low-grade dysplasia in Barrett's esophagus-an innocent bystander? Contra Endosc 39 647 649
82. LA Anderson LJ Murray SJ Murphy, et al. 2003 Mortality in Barrett's oesophagus: results from a population based study Gut 52 1081 1084 12865262
83. DE Fleischer BF Overholt VK Sharma, et al. 2008 Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up Gastrointest Endosc 68 5 867 876 18561930
84. WD Lyday FS Corbett DA Kuperman, et al. 2010 Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry Endoscopy 42 4 272 278 20146164
85. V Velanovich 2009 Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned Surg Endosc 23 10 2175 2180 19263139
86. SM Eldaif E Lin KA Singh, et al. 2009 Radiofrequency ablation of Barrett's esophagus: short-term results Ann Thorac Surg 87 2 405 410 19161747
87. VK Sharma HJ Kim A Das, et al. 2008 A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system) Endoscopy 40 5 380 387 18459074
88. VK Sharma HJ Kim A Das, et al. 2009 Circumferential and focal ablation of Barrett's esophagus containing dysplasia Am J Gastroenterol 104 2 310 317 19174783
89. SD Finkelstein WD Lyday 2008 The molecular pathology of radiofrequency mucosal ablation of Barrett's esophagus Gastroenterology 134 A436
90. R Vij G Triadafilopoulos DK Owens P Kunz GD Sanders 2004 Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus Gastrointest Endosc 60 5 739 756 15557950
91. NJ Shaheen JM Inadomi BF Overholt P Sharma 2004 What is the best management strategy for high-grade dysplasia in Barrett's oesophagus? A cost-effectiveness analysis Gut 53 12 1736 1744 15542506
92. K Ragunath N Krasner VS Raman, et al. 2005 Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness Scand J Gastroenterol 40 7 750 758 16118910
93. A Das C Wells HJ Kim, et al. 2009 An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus Endoscopy 41 5 400 408 19418393
94. JM Inadomi M Somsouk RD Madanick, et al. 2009 A cost-utility analysis of ablative therapy for Barrett's esophagus Gastroenterology 136 2101 2114 19272389
95. B Levin DA Lieberman B McFarland, et al. 2008 Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 1570 1595 18384785 (Pubitemid 351615355)
96. SJ Winawer AG Zauber MN Ho, et al. 1993 Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 1977 1981 8247072
97. K Leung P Pinsky AO Laiyemo, et al. 2010 Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study Gastrointest Endosc 71 1 111 117 19647250
98. DJ Robertson ER Greenberg M Beach, et al. 2005 Colorectal cancer in patients under close colonoscopic surveillance Gastroenterology 129 34 41 16012932
99. K Ragunath N Krasner VA Raman, et al. 2005 Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness Scand J Gastroenterol 40 750 758 16118910
100. SE Attwood CJ Lewis S Caplin, et al. 2003 Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus Clin Gastroenterol Hepatol 1 258 263 15017666
101. S Wani H Sayana P Sharma 2010 Endoscopic eradication of Barrett's esophagus Gastrointest Endosc 71 1 147 166 19879565
102. DI Watson D Foreman PG Devitt GG Jamieson 1997 Preoperative grading of esophagitis versus outcome following laparoscopic Nissen fundoplication Am J Gastroenterol 92 222 225 9040195
103. RJ Landreau RJ Wiechmann SR Hazelrigg, et al. 1998 Success of laparoscopic fundoplication for gastroesophageal reflux disease Ann Thorac Surg 66 1886 1893
104. V Ozmen ES Oran E Gorgun, et al. 2006 Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett's esophagus Surg Endosc 20 2 226 229 16362470
105. RS dos Santos C Bizekis M Ebright, et al. 2010 Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm J Thorac Cardiovasc Surg 139 3 713 716 20074750
106. G Triadafilopoulos 2010 Blitzkreig for Barrett's esophagus containing early neoplasia Clin Gastroenterol Hepatol 8 7 9 19788932